Acadia Healthcare Company, Inc. - Common Stock (ACHC)
23.91
-4.35 (-15.39%)
NASDAQ · Last Trade: Apr 30th, 1:28 PM EDT
Detailed Quote
Previous Close
28.26
Open
27.13
Bid
23.90
Ask
23.91
Day's Range
21.60 - 27.71
52 Week Range
11.43 - 28.57
Volume
5,751,110
Market Cap
2.20B
PE Ratio (TTM)
-1.966
EPS (TTM)
-12.2
Dividend & Yield
N/A (N/A)
1 Month Average Volume
2,747,506
Chart
About Acadia Healthcare Company, Inc. - Common Stock (ACHC)
Acadia Healthcare Company is a leading provider of behavioral healthcare services, specializing in the treatment and management of mental health and substance use disorders. With a network of facilities across the United States, Acadia operates a range of inpatient and outpatient programs designed to deliver high-quality care tailored to the unique needs of individuals facing psychological challenges. The company is committed to improving patient outcomes through evidence-based practices, compassionate treatment approaches, and a focus on fostering a supportive recovery environment. Acadia's mission is to enhance the overall well-being of its patients and communities by providing accessible and effective mental health solutions. Read More
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them...
Behavioral health company Acadia Healthcare (NASDAQ:ACHC) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 7.6% year on year ...
Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026.
Behavioral health company Acadia Healthcare (NASDAQ:ACHC) will be announcing earnings results this Wednesday after market hours. Here’s what investors should...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged...
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Acadia Healthcare currently trades at $24.37 per share and has shown little upside over the past six months, posting a small loss of 0.7%. Is now the time to...
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding...
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia”) today announced that it has appointed Daniel Cancelmi to its Board of Directors, effective immediately.
In a move that signals a definitive shift toward a hybrid future for mental healthcare, Universal Health Services (NYSE: UHS) announced yesterday, March 9, 2026, that it has entered into a definitive agreement to acquire the virtual mental health giant Talkspace (NASDAQ: TALK). The deal, valued at $5.25 per
In a move that signals a permanent marriage between traditional brick-and-mortar medicine and digital health, Universal Health Services (NYSE: UHS) announced today, March 9, 2026, a definitive agreement to acquire Talkspace (Nasdaq: TALK) for approximately $835 million. The deal, valued at $5.25 per share in an all-cash transaction, represents
In a move that signals a paradigm shift for the behavioral health industry, Universal Health Services (NYSE: UHS) announced today, March 9, 2026, that it has entered into a definitive agreement to acquire Talkspace (NASDAQ: TALK) for approximately $835 million. The deal, valued at $5.25 per share in an
Looking back on hospital chains stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Acadia Healthcare (NASDAQ:ACHC) and its peers.
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead.
They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Behavioral health company Acadia Healthcare (NASDAQ:ACHC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.1% year on year to $821.5 million. Guidance for next quarter’s revenue was optimistic at $825 million at the midpoint, 2.6% above analysts’ estimates. Its non-GAAP profit of $0.07 per share was significantly above analysts’ consensus estimates.
Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025.
